A W Karchmer

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Nosocomial bloodstream infections: organisms, risk factors, and implications
    A W Karchmer
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Clin Infect Dis 31:S139-43. 2000
  2. ncbi request reprint Infections of intracardiac devices
    Adolf W Karchmer
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Kennedy 6, Boston, MA 02215, USA
    Infect Dis Clin North Am 16:477-505, xii. 2002
  3. ncbi request reprint Infections of intracardiac devices
    Adolf W Karchmer
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston
    Cardiol Clin 21:253-71, vii. 2003
  4. ncbi request reprint Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly
    D N Fisman
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, and Harvard Center for Risk Analysis, Harvard School of Public Health, Boston, MA, USA
    Clin Infect Dis 32:419-30. 2001
  5. pmc Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients
    Stephen G Weber
    Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
    Emerg Infect Dis 9:1415-22. 2003
  6. ncbi request reprint Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia
    T Lalani
    Division of Infectious Diseases, Duke Clinical Research Institute, Durham, NC, USA
    J Antimicrob Chemother 61:177-82. 2008
  7. ncbi request reprint The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges
    Sara E Cosgrove
    Division of Infectious Diseases, Johns Hopkins Medical Institutions, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA
    Infect Control Hosp Epidemiol 26:166-74. 2005
  8. ncbi request reprint Preventing the influx of vancomycin-resistant enterococci into health care institutions, by use of a simple validated prediction rule
    Evelina Tacconelli
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Clin Infect Dis 39:964-70. 2004
  9. ncbi request reprint Non-HACEK gram-negative bacillus endocarditis
    Susan Morpeth
    Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina 27710, USA
    Ann Intern Med 147:829-35. 2007
  10. ncbi request reprint Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-2004. A 75-year-old woman with acute onset of chest pain followed by fever
    Adolf W Karchmer
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center Boston, USA
    N Engl J Med 351:1240-8. 2004

Collaborators

Detail Information

Publications24

  1. ncbi request reprint Nosocomial bloodstream infections: organisms, risk factors, and implications
    A W Karchmer
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Clin Infect Dis 31:S139-43. 2000
    ..Therefore, newer, more effective antimicrobial therapies are needed to treat BSIs caused by gram-positive cocci are needed...
  2. ncbi request reprint Infections of intracardiac devices
    Adolf W Karchmer
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Kennedy 6, Boston, MA 02215, USA
    Infect Dis Clin North Am 16:477-505, xii. 2002
    ..This article reviews the epidemiology, microbiology, clinical presentation, and medical as well as surgical therapy of intracardiac device infections...
  3. ncbi request reprint Infections of intracardiac devices
    Adolf W Karchmer
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston
    Cardiol Clin 21:253-71, vii. 2003
    ..This article reviews the epidemiology, microbiology, clinical presentation, and medical as well as surgical therapy of intracardiac device infections...
  4. ncbi request reprint Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly
    D N Fisman
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, and Harvard Center for Risk Analysis, Harvard School of Public Health, Boston, MA, USA
    Clin Infect Dis 32:419-30. 2001
    ..In the absence of prospective clinical trials, debridement and retention is a reasonable strategy for treatment of older persons with staphylococcal or streptococcal infection and a nonloosened prosthesis...
  5. pmc Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients
    Stephen G Weber
    Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
    Emerg Infect Dis 9:1415-22. 2003
    ..4; p <0.0001; ciprofloxacin OR 2.5; p = 0.005) but not MSSA. Exposure to levofloxacin or ciprofloxacin is a significant risk factor for the isolation of MRSA, but not MSSA...
  6. ncbi request reprint Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia
    T Lalani
    Division of Infectious Diseases, Duke Clinical Research Institute, Durham, NC, USA
    J Antimicrob Chemother 61:177-82. 2008
    ..To evaluate the clinical characteristics, treatment and outcomes of patients with osteoarticular infections (OAIs) associated with Staphylococcus aureus bacteraemia (SAB)...
  7. ncbi request reprint The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges
    Sara E Cosgrove
    Division of Infectious Diseases, Johns Hopkins Medical Institutions, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA
    Infect Control Hosp Epidemiol 26:166-74. 2005
    ..To evaluate the impact of methicillin resistance in Staphylococcus aureus on mortality, length of hospitalization, and hospital charges...
  8. ncbi request reprint Preventing the influx of vancomycin-resistant enterococci into health care institutions, by use of a simple validated prediction rule
    Evelina Tacconelli
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Clin Infect Dis 39:964-70. 2004
    ..The goal of this study was to develop a validated prediction rule for identification of patients harboring vancomycin-resistant enterococci (VRE) at hospital admission...
  9. ncbi request reprint Non-HACEK gram-negative bacillus endocarditis
    Susan Morpeth
    Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina 27710, USA
    Ann Intern Med 147:829-35. 2007
    ....
  10. ncbi request reprint Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-2004. A 75-year-old woman with acute onset of chest pain followed by fever
    Adolf W Karchmer
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center Boston, USA
    N Engl J Med 351:1240-8. 2004
  11. ncbi request reprint Increased antibiotic resistance in respiratory tract pathogens: PROTEKT US--an update
    Adolf W Karchmer
    Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215 5399, USA
    Clin Infect Dis 39:S142-50. 2004
    ..The patterns of resistance detected by these major surveillance programs are a warning signal regarding the continued emergence of resistance among community-acquired respiratory tract pathogens...
  12. ncbi request reprint Epidemiological comparison of true methicillin-resistant and methicillin-susceptible coagulase-negative staphylococcal bacteremia at hospital admission
    Evelina Tacconelli
    Beth Israel Deaconess Medical Center and Division of Infectious Diseases, Harvard Medical School, Boston, Massachusetts 02215, USA
    Clin Infect Dis 37:644-9. 2003
    ....
  13. doi request reprint Methicillin-resistant Staphylococcus aureus: an evolving clinical challenge
    Adolf W Karchmer
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Clin Infect Dis 46:S342-3. 2008
  14. ncbi request reprint Detection of Staphylococcus aureus in peripheral blood stem cell cultures after sterilization of standard blood cultures
    Mitchell J Schwaber
    Department of Medicine, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    J Clin Apher 18:37-9. 2003
    ..Cultures of apheresis product may be more sensitive to the presence of bacteremia than standard blood cultures, and they should guide clinical decisions when the bacteria isolated are potential pathogens or suggest clinical infection...
  15. doi request reprint Risk factors for albicans and non-albicans candidemia in the intensive care unit
    Jennifer K Chow
    Division of Geographic Medicine and Infectious Diseases, Tufts New England Medical Center, Tufts University School of Medicine, Boston, MA, USA
    Crit Care Med 36:1993-8. 2008
    ..To determine risk factors for bloodstream infections (BSI) with Candida non-albicans (C-NA) species and Candida albicans (CA) among critically ill patients...
  16. ncbi request reprint Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis
    Sara E Cosgrove
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts, USA
    Clin Infect Dis 36:53-9. 2003
    ..54-2.42; P<.001); significant heterogeneity was present. We explored the reasons for heterogeneity by means of subgroup analyses. MRSA bacteremia is associated with significantly higher mortality rate than is MSSA bacteremia...
  17. ncbi request reprint Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
    Vance G Fowler
    Duke University Medical Center, Durham, NC 27710, USA
    N Engl J Med 355:653-65. 2006
    ..Alternative therapies for Staphylococcus aureus bacteremia and endocarditis are needed...
  18. doi request reprint Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit
    Jennifer K Chow
    Division of Geographic Medicine and Infectious Diseases, Tufts New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    Clin Infect Dis 46:1206-13. 2008
    ..We examined factors associated with BSIs due to non-albicans Candida species, compared with C. albicans BSIs, in an ICU patient population...
  19. ncbi request reprint Prosthetic joint infections
    Irene G Sia
    Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Infect Dis Clin North Am 19:885-914. 2005
    ..If surgery is not possible, an alternative is long-term oral antimicrobial suppression to maintain a functioning prosthesis. Treatment must be individualized for a specific infection in a specific patient...
  20. ncbi request reprint Diagnosis and treatment of diabetic foot infections
    Benjamin A Lipsky
    Medical Service, Veterans Affairs Puget Sound Health Care System, and Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98108 9804, USA
    Clin Infect Dis 39:885-910. 2004
  21. ncbi request reprint Cardiology patient page. Bacterial endocarditis: the disease, treatment, and prevention
    Christopher H Cabell
    Duke University School of Medicine and Duke Clinical Research Institute, Durham, NC, USA
    Circulation 107:e185-7. 2003
  22. ncbi request reprint A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects
    John H Rex
    Division of Infectious Diseases, University of Texas Medical School, Houston, TX 77030, USA
    Clin Infect Dis 36:1221-8. 2003
    ..02). In nonneutropenic subjects, the combination of fluconazole plus AmB was not antagonistic compared with fluconazole alone, and the combination trended toward improved success and more-rapid clearance from the bloodstream...
  23. ncbi request reprint Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy
    Carol L Addy
    Department of Internal Medicine, Endocrinology Hypertension Division, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    J Clin Endocrinol Metab 88:627-36. 2003
    ..Thus, adiponectin replacement may be a potential treatment option to ameliorate the metabolic changes observed in this patient population...
  24. ncbi request reprint Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial
    Mindy G Schuster
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Ann Intern Med 149:83-90. 2008
    ..Invasive infection with Candida species is an important cause of morbidity and mortality in intensive care unit (ICU) patients. Optimal preventive strategies have not been clearly defined...